Published in Experientia on March 15, 1996
Transfer of ascorbic acid across the vascular endothelium: mechanism and self-regulation. Am J Physiol Cell Physiol (2009) 1.12
Ascorbic acid prevents increased endothelial permeability caused by oxidized low density lipoprotein. Free Radic Res (2010) 0.92
Ascorbic acid efflux and re-uptake in endothelial cells: maintenance of intracellular ascorbate. Mol Cell Biochem (2009) 0.91
Nitric oxide mediates tightening of the endothelial barrier by ascorbic acid. Biochem Biophys Res Commun (2010) 0.89
Cobalt-induced oxidant stress in cultured endothelial cells: prevention by ascorbate in relation to HIF-1alpha. Biofactors (2009) 0.86
Oxidized LDL up-regulates the ascorbic acid transporter SVCT2 in endothelial cells. Mol Cell Biochem (2010) 0.81
Intracellular Ascorbate Prevents Endothelial Barrier Permeabilization by Thrombin. J Biol Chem (2015) 0.80
Chelation of intracellular iron enhances endothelial barrier function: a role for vitamin C? Arch Biochem Biophys (2010) 0.78
Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit Care Med (2001) 2.26
Imipenem/vancomycin for Rhodococcus equi pulmonary infection in HIV-positive patient. Lancet (1991) 1.66
Monoclonal and oligoclonal gammopathies in heart-transplant recipients. Clin Chem (1991) 1.54
Simultaneous determination of serum neopterin and C-reactive protein as markers of infection in heart-transplant recipients. Clin Chem (1989) 1.52
HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol (1997) 1.51
Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin Chim Acta (1982) 1.24
A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb (1994) 1.19
Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome. J Clin Immunol (2008) 1.13
Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant (2001) 1.08
Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol (1998) 1.07
Study of minimal inhibitory concentration of antibiotics on bacteria cultivated in vitro in space (Cytos 2 experiment). Aviat Space Environ Med (1985) 1.07
Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J Lipid Res (1996) 1.04
Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radic Biol Med (2001) 1.03
UVA-induced lipid peroxidation in cultured human fibroblasts. Biochim Biophys Acta (1991) 1.03
Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem (1984) 1.03
[In vitro activity of twenty antibiotics against Rhodococcus equi]. Pathol Biol (Paris) (1991) 1.01
Antibiotic activity in space. Drugs Exp Clin Res (1986) 0.99
Prolidase and prolidase deficiency. Life Sci (1984) 0.97
Lysosomes, a key target of hydrophobic photosensitizers proposed for photochemotherapeutic applications. J Photochem Photobiol B (1993) 0.92
Oxidized LDL induces an oxidative stress and activates the tumor suppressor p53 in MRC5 human fibroblasts. Biochem Biophys Res Commun (2000) 0.91
Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats. Nephrol Dial Transplant (2000) 0.91
Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem Biophys Res Commun (1999) 0.90
Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus. Lupus (2010) 0.90
Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI. J Clin Invest (1995) 0.90
Alteration of the endocytotic pathway by photosensitization with fluoroquinolones. Photochem Photobiol (2000) 0.89
Coronary calcification and its relation to extracoronary atherosclerosis in asymptomatic hypercholesterolemic men. The PCV METRA Group. Circulation (1992) 0.89
Changes in prolinase and prolidase activity during CCl4 administration inducing liver cytolysis and fibrosis in rat. Br J Exp Pathol (1987) 0.88
Human ApoA-IV overexpression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler Thromb Vasc Biol (2000) 0.88
Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis (2001) 0.87
Preliminary results of the "Antibio" experiment. Naturwissenschaften (1986) 0.86
Growth and division of Escherichia coli under microgravity conditions. Res Microbiol (1994) 0.86
Intra and intermolecular charge effects on the reaction of the superoxide radical anion with semi-oxidized tryptophan in peptides and N-acetyl tryptophan. Free Radic Res (1998) 0.86
Oxidized LDL activates STAT1 and STAT3 transcription factors: possible involvement of reactive oxygen species. FEBS Lett (1999) 0.86
Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang (1997) 0.86
Behavior of bacteria and antibiotics under space conditions. Aviat Space Environ Med (1994) 0.86
In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts. FEBS Lett (1986) 0.86
Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis (1991) 0.85
Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease. Pediatr Nephrol (2004) 0.85
UV-A irradiation induces a decrease in the mitochondrial respiratory activity of human NCTC 2544 keratinocytes. Free Radic Res (2001) 0.85
A new DNA polymorphism in the 5' untranslated region of the human SREBP-1a is related to development of atherosclerosis in high cardiovascular risk population. Atherosclerosis (2001) 0.85
Photodecontamination of blood components: advantages and drawbacks. Clin Hemorheol Microcirc (1998) 0.85
A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler Thromb Vasc Biol (1996) 0.85
Lovastatin enhances the photocytotoxicity of UVA radiation towards cultured N.C.T.C. 2544 human keratinocytes: prevention by cholesterol supplementation and by a cathepsin inhibitor. Biochem J (1995) 0.84
Subcellular localization of and photosensitization by protoporphyrin IXhuman keratinocytes and fibroblasts cultivated with 5-aminolevulinic acid. Photochem Photobiol (1995) 0.84
A method to screen for the antioxidant effect of compounds on low-density lipoprotein (LDL): illustration with flavonoids. J Pharmacol Toxicol Methods (1993) 0.84
Amino acid transport systems in the human hepatoma cell line Hep G2. Biochem Biophys Res Commun (1992) 0.84
Ultraviolet-A induces activation of AP-1 in cultured human keratinocytes. FEBS Lett (1996) 0.84
Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin cholesterol acyltransferase activation. Atherosclerosis (1993) 0.84
Effect of cyclic AMP on low density lipoprotein binding and internalization by cultured human fibroblasts. Biochem Biophys Res Commun (1983) 0.83
Collagen biosynthesis anomalies in prolidase deficiency: effect of glycyl-L-proline on the degradation of newly synthesized collagen. Clin Physiol Biochem (1989) 0.83
Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts. Biochim Biophys Acta (1992) 0.83
Lipid peroxidation abnormalities in hemodialyzed patients. Nephron (1993) 0.83
Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats. Am J Physiol Renal Physiol (2001) 0.83
Changes in phospholipid polar head group turnover in SV40-transformed hamster fibroblasts. FEBS Lett (1982) 0.83
Abnormalities of lipid metabolism and arterial rigidity in young subjects with borderline hypertension. Clin Invest Med (1994) 0.82
Defective galactose oxidation in a patient with glycogen storage disease and Fanconi syndrome. Pediatr Res (1983) 0.82
Preliminary results of Cytos 2 experiment. Acta Astronaut (1985) 0.82
Contrasting effects of excess ferritin expression on the iron-mediated oxidative stress induced by tert-butyl hydroperoxide or ultraviolet-A in human fibroblasts and keratinocytes. J Photochem Photobiol B (2000) 0.82
Cell density affects prolidase and prolinase activity and intracellular amino acid levels in cultured human cells. Clin Chim Acta (1985) 0.82
Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic men. PCVMETRA Group. Arterioscler Thromb (1994) 0.82
Plasma prolidase and prolinase activity in alcoholic liver disease. Clin Chim Acta (1988) 0.82
UVA radiation stimulates ceramide production: relationship to oxidative stress and potential role in ERK, JNK, and p38 activation. Biochem Biophys Res Commun (2001) 0.82
Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography. J Lipid Res (1991) 0.81
Homocysteine decreases endothelin-1 production by cultured human endothelial cells. Eur J Biochem (1999) 0.81
Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience. Clin Biochem (1991) 0.81
Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron (1991) 0.81
[Hepatic glycogenoses. Introduction]. Ann Gastroenterol Hepatol (Paris) (1988) 0.81
[Biological and physiopathological aspects of hepatic glycogenoses]. Ann Gastroenterol Hepatol (Paris) (1988) 0.80
Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol (1999) 0.80
Rapid analysis of cellular lipids without extraction. J Biochem Biophys Methods (1987) 0.80
Enhancement of phospholipid methylation in cultured hamster cells by viral transformation. FEBS Lett (1981) 0.80
Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study. Rheumatology (Oxford) (2008) 0.80
Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo. Cancer Res (1998) 0.80
Uptake by cells and photosensitizing effectiveness of novel pheophorbide derivatives in vitro. Int J Cancer (1995) 0.80
Endothelin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transplant (1998) 0.80
Transport of L-histidine by human diploid fibroblasts in culture. In Vitro (1983) 0.79
Lovastatin potentiates the photocytotoxic effect of photofrin II delivered to HT29 human colonic adenocarcinoma cells by low density lipoprotein. Photochem Photobiol (1993) 0.79
Synthesis, cellular uptake of, and cell photosensitization by a porphyrin bearing a quinoline group. J Photochem Photobiol B (1990) 0.79
Ultraviolet A decreases epidermal growth factor (EGF) processing in cultured human fibroblasts and keratinocytes: inhibition of EGF-induced diacylglycerol formation. J Invest Dermatol (1994) 0.79
Use of platelets, mononuclear and polymorphonuclear cells in the diagnosis of glycogen storage disease type VI. J Inherit Metab Dis (1988) 0.79
Restoration of immune response by a cationic amphiphilic drug (AY 9944) in vitro: a new approach To chemotherapy against human immunodeficiency virus type 1. Antimicrob Agents Chemother (1998) 0.79
High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells. Biochem J (1996) 0.79
Phenothiazines inhibit copper and endothelial cell-induced peroxidation of low density lipoprotein. A comparative study with probucol, butylated hydroxytoluene and vitamin E. Biochem Pharmacol (1990) 0.79
Carbon disulfide modification and impaired catabolism of low density lipoprotein. Atherosclerosis (1989) 0.79
[Effect of cycloleucine on renal uptake of dibasic amino acids and cystine]. Biomedicine (1976) 0.79